Kihealth Diabetes Risk Test
- Diagnostic At-Home Test
- Examines Four Biomarkers
- Includes Innovative Test of Beta Cell Turnover
- American Diabetes Association "Innovation of the Year" Winner
$279.00
Product Description
The Diabetes Risk test from Kihealth uses a novel test developed at Yale University that is the first early detection method that examines beta cell turnover. This provides an initial insight into your risk of developing diabetes. By combining this innovative biomarker with a c-peptide test (to measure beta cell function), an insulin test, and a HbA1C test, the Diabetes Risk test offers the most comprehensive diabetes risk assessment available.
Detecting diabetes early provides numerous advantages, such as the opportunity for earlier intervention and potentially mitigating or reducing the severity of the disease.
The Diabetes Risk test recently won the 2025 "Innovation of the Year" award from the American Diabetes Association.
